Posted on Wednesday, 23 December 2009 by
John Carroll
Sanofi-Aventis' strategy to do more partnering with the world's most promising biotech companies may spur the pharma giant to take a $143 million stake in Denmark's Zealand Pharma. The two companies are already partnered on AVE0010/ZP10 for Type 2 diabetes, and a European newspaper reports that Sanofi is interested in snagging a 19.9 percent chunk of equity in Zealand.
- here's the
report from
Reuters
Read the full article at FierceBiotech